Mitsubishi UFJ Asset Management Co. Ltd. Acquires 10,206 Shares of Bruker Co. (NASDAQ:BRKR)

Mitsubishi UFJ Asset Management Co. Ltd. grew its holdings in shares of Bruker Co. (NASDAQ:BRKR) by 38.6% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 36,628 shares of the medical research company’s stock after buying an additional 10,206 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd.’s holdings in Bruker were worth $2,188,000 as of its most recent filing with the SEC.

Other hedge funds also recently modified their holdings of the company. State Street Corp raised its holdings in shares of Bruker by 9.6% during the third quarter. State Street Corp now owns 3,627,300 shares of the medical research company’s stock valued at $250,501,000 after purchasing an additional 318,808 shares during the period. RTW Investments LP raised its stake in Bruker by 1.1% during the 3rd quarter. RTW Investments LP now owns 3,481,119 shares of the medical research company’s stock worth $240,406,000 after buying an additional 37,024 shares during the period. Geode Capital Management LLC boosted its holdings in Bruker by 10.8% in the third quarter. Geode Capital Management LLC now owns 1,993,468 shares of the medical research company’s stock worth $137,702,000 after acquiring an additional 193,580 shares in the last quarter. Vaughan Nelson Investment Management L.P. grew its stake in Bruker by 140.3% in the fourth quarter. Vaughan Nelson Investment Management L.P. now owns 1,141,762 shares of the medical research company’s stock valued at $66,930,000 after acquiring an additional 666,617 shares during the period. Finally, Bank of New York Mellon Corp grew its stake in Bruker by 7.6% in the fourth quarter. Bank of New York Mellon Corp now owns 988,863 shares of the medical research company’s stock valued at $57,967,000 after acquiring an additional 69,806 shares during the period. Institutional investors own 79.52% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on BRKR. Bank of America increased their target price on Bruker from $78.00 to $80.00 and gave the stock a “buy” rating in a report on Friday, December 13th. Guggenheim reiterated a “buy” rating on shares of Bruker in a report on Monday, February 24th. The Goldman Sachs Group upgraded shares of Bruker from a “sell” rating to a “neutral” rating and set a $60.00 target price on the stock in a report on Thursday, December 5th. UBS Group began coverage on Bruker in a research note on Tuesday, December 10th. They set a “neutral” rating and a $66.00 price target for the company. Finally, Stifel Nicolaus lowered their price objective on Bruker from $70.00 to $57.00 and set a “hold” rating for the company in a research note on Friday, February 14th. Six research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $70.50.

Bruker Trading Down 3.3 %

NASDAQ:BRKR opened at $40.38 on Wednesday. Bruker Co. has a 12 month low of $40.34 and a 12 month high of $92.93. The company has a current ratio of 1.60, a quick ratio of 0.77 and a debt-to-equity ratio of 1.15. The firm’s 50 day moving average is $49.85 and its 200 day moving average is $56.57. The stock has a market capitalization of $6.13 billion, a PE ratio of 53.13, a price-to-earnings-growth ratio of 2.16 and a beta of 1.18.

Bruker (NASDAQ:BRKR) last issued its quarterly earnings results on Thursday, February 13th. The medical research company reported $0.76 EPS for the quarter, beating analysts’ consensus estimates of $0.75 by $0.01. Bruker had a return on equity of 21.01% and a net margin of 3.36%. Sell-side analysts expect that Bruker Co. will post 2.69 earnings per share for the current year.

Bruker Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, March 28th. Stockholders of record on Monday, March 17th were given a $0.05 dividend. This represents a $0.20 annualized dividend and a dividend yield of 0.50%. The ex-dividend date of this dividend was Monday, March 17th. Bruker’s dividend payout ratio (DPR) is currently 26.32%.

Bruker Company Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.